![Ying Huang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ying Huang
Fortuna: 2 M $ al 31/12/2025
Perfil
En la actualidad, Ying Huang ocupa el cargo de Director Ejecutivo y Financiero de Legend Biotech Corp. En su anterior carrera, el Dr. Huang ocupó el cargo de Científico Principal en Schering-Plough Corp., Analista de Investigación en Credit Suisse Securities (USA) LLC (Broker), Analista Asociado en Wachovia Securities LLC, Vicepresidente y Analista Senior en Barclays Capital, Inc. y Analista de Investigación en Merrill Lynch, Pierce, Fenner & Smith, Inc. y Analista de Investigación en Gleacher & Co. Securities, Inc. El Dr. Huang obtuvo un doctorado y un título de posgrado en The Trustees of Columbia University en la ciudad de Nueva York y una licenciatura en la Universidad de Ciencia y Tecnología de China.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LEGEND BIOTECH CORP. 0,07 % | 11/03/2025 | 214.364 ( 0,07 % ) | 2 M $ | 31/12/2025 |
Cargos activos de Ying Huang
| Empresas | Cargo | Inicio |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Director Ejecutivo | 21/09/2020 |
Quanta Therapeutics, Inc.
 Quanta Therapeutics, Inc. Develops biotechnologies | Director/Miembro de la Junta | 01/02/2022 |
Antiguos cargos conocidos de Ying Huang.
| Empresas | Cargo | Fin |
|---|---|---|
BofA Securities, Inc.
 BofA Securities, Inc. Operates as a brokerage firm that purchases and sells corporate debt & equity securities and financial instruments | Corporate Officer/Principal | 01/07/2019 |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
 Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 13/05/2019 |
Schering-Plough Corp.
 Schering-Plough Corp. Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | - |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 31/07/2014 |
Gleacher & Co. Securities, Inc.
 Gleacher & Co. Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Formación de Ying Huang.
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 11 |
|---|---|
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Provides brokerage services | |
Schering-Plough Corp.
Schering-Plough Corp. Manufactures and sells pharmaceutical & health care products | |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wachovia Securities LLC
 Wachovia Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Science & Technology of China
 University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Gleacher & Co. Securities, Inc.
Gleacher & Co. Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Legend Biotech Corp.
 Legend Biotech Corp. Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | |
BofA Securities, Inc.
BofA Securities, Inc. Operates as a brokerage firm that purchases and sells corporate debt & equity securities and financial instruments | |
Quanta Therapeutics, Inc.
Quanta Therapeutics, Inc. Develops biotechnologies |
- Bolsa de valores
- Insiders
- Ying Huang
